Effects of DPP4 Inhibition on COVID-19

Stopped Logistical challenges amid COVID-19 pandemic and lack of financial support

Conditions

• Coronavirus Infection
• Type 2 Diabetes

Interventions

• DRUG: Linagliptin
• DRUG: Insulin regimen

Sponsor

University of Miami